PAX5 and precursor B-cell acute lymphoblastic leukemia: Indeed, heterozygous deletions of PAX5 are found in approximately one third of B-ALL patients (103), and the mouse model shows that the absence of PAX5 blocks the transition between pre-Pro-B and Pro-B stages during B differentiation.